This Federal Circuit opinion analyzes various key issues in patent litigation, including the role of applicant admitted prior art (“AAPA”), standing, and obviousness.
Background -
Shockwave Medical, Inc. (“Shockwave”)...more
This Federal Circuit opinion analyzes lexicography in the context of claim construction.
Alnylam Pharmaceuticals owns U.S. Patent Nos. 11,246,933 (parent) and 11,382,979 (child). These patents relate to biodegradable...more
7/22/2025
/ Biotechnology ,
Claim Construction ,
Coronavirus/COVID-19 ,
Intellectual Property Protection ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
USPTO ,
Vaccinations
This Federal Circuit opinion analyzes claim construction arguments and requests for remittitur in the context of preserving issues for appeal.
Background -
Belanger is a manufacturer of car wash systems. Belanger owns...more